Author

Richard M. Fagerstrom

Observed names: Fagerstrom, Richard M., R Fagerstrom, R. Fagerstrom, R. M. Fagerstrom, R.M. Fagerstrom, Richard Fagerstrom, Richard Fagerstrom, Jr., Richard M Fagerstrom

Institution: National Cancer Institute

Observed institutions: University of North Carolina at Chapel Hill, United States Department of Health and Human Services, National Institutes of Health, Mount Sinai Hospital, Mayo Clinic, Henry Ford Health, City University of New York, University of Utah, Huntsman Cancer Institute, Information Management Services, CCS Associates (United States), National Cancer Institute, Office of Disease Prevention, Division of Cancer Epidemiology and Genetics, Marshfield Clinic Research Foundation, New York University, Icahn School of Medicine at Mount Sinai

OpenAlex ID: A5105541933

Results of the Two Incidence Screenings in the National Lung Screening Trial

2013 · Denise R. Aberle, Sarah DeMello, et al. · New England Journal of Medicine · 550

PDF

Lung Cancer Mortality in the Mayo Lung Project: Impact of Extended Follow-up

2000 · P. M. Marcus, E. J. Bergstralh, et al. · JNCI Journal of the National Cancer Institute · 522

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial

2005 · Saundra S. Buys, Edward Partridge, et al. · American Journal of Obstetrics and Gynecology · 346

A Survey of Clinical Trials of Antibiotic Prophylaxis in Colon Surgery: Evidence against Further Use of No-Treatment Controls

1981 · Mark L. Baum, David S. Anish, et al. · New England Journal of Medicine · 340

Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer

2004 · John K. Gohagan, Pamela M. Marcus, et al. · Lung Cancer · 300

Effects of Intracoronary Streptokinase and Intracoronary Nitroglycerin Infusion on Coronary Angiographic Patterns and Mortality in Patients with Acute Myocardial Infarction

1984 · K. Peter Rentrop, Frederick Feit, et al. · New England Journal of Medicine · 283

Baseline Findings of a Randomized Feasibility Trial of Lung Cancer Screening With Spiral CT Scan vs Chest Radiograph

2004 · John Gohagan, Pamela Marcus, et al. · CHEST Journal · 279

Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening

2009 · J. M. Croswell, B. S. Kramer, et al. · The Annals of Family Medicine · 152

PDF

Marked Decline in Trabecular Bone Mineral Content in Healthy Men with Age: Lack of Association with Sex Steroid Levels

1987 · Diane E. Meier, Eric S. Orwoll, et al. · Journal of the American Geriatrics Society · 131

Lung Cancer: Interobserver Agreement on Interpretation of Pulmonary Findings at Low-Dose CT Screening

2007 · David S. Gierada, Thomas K. Pilgram, et al. · Radiology · 116

Characterization of hypocholesterolemia in myeloproliferative disease

1981 · Harriet S. Gilbert, Henry Ginsberg, et al. · The American Journal of Medicine · 102

Prenatal sonographic assessment of the fetal thorax: Normal values

1987 · Usha Chitkara, Joanne Rosenberg, et al. · American Journal of Obstetrics and Gynecology · 94

Deficiencies of Clinical Trials of Alcohol Withdrawal

1983 · Gail Moskowitz, Thomas C. Chalmers, et al. · Alcoholism Clinical and Experimental Research · 75

Endocrine evaluation of forty female-to-male transsexuals: Increased frequency of polycystic ovarian disease in female transsexualism

1986 · Walter Futterweit, Richard A. Weiss, et al. · Archives of Sexual Behavior · 71

Prevalence and significance of residual flow to the infarct zone during the acute phase of myocardial infarction

1985 · Heiner Blanke, Marc Cohen, et al. · Journal of the American College of Cardiology · 69

PDF

Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease

1984 · Henry Ginsberg, Gregory A. Grabowski, et al. · Clinical Genetics · 56

Design and evolution of the data management systems in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

2000 · Marsha A. Hasson, Richard M. Fagerstrom, et al. · Controlled Clinical Trials · 41

A Class of Weighted Log-Rank Tests for Survival Data When the Event is Rare

2000 · Steven Buyske, Richard Fagerstrom, et al. · Journal of the American Statistical Association · 37

Toenail selenium concentration and lung cancer in male smokers (Finland)

2002 · Terryl J. Hartman, Philip R. Taylor, et al. · Cancer Causes & Control · 34

CT Quality Assurance in the Lung Screening Study Component of the National Lung Screening Trial: Implications for Multicenter Imaging Trials

2009 · David S. Gierada, Kavita Garg, et al. · American Journal of Roentgenology · 30

Prostate Specific Antigen Changes as Related to the Initial Prostate Specific Antigen: Data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

2006 · E. David Crawford, Paul F. Pinsky, et al. · The Journal of Urology · 30

Ovarian Cancer Screening in Women With a Family History of Breast or Ovarian Cancer

2006 · James V. Lacey, Mark H. Greene, et al. · Obstetrics and Gynecology · 28

Estimating the Cumulative Risk of a False‐Positive Test in a Repeated Screening Program

2004 · Jian‐Lun Xu, Richard M. Fagerstrom, et al. · Biometrics · 28

The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity

2019 · Lori M. Minasian, Eileen Dimond, et al. · JACC CardioOncology · 27

PDF

Quality control of cancer screening examination procedures in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

2000 · Joel L. Weissfeld, Richard M. Fagerstrom, et al. · Controlled Clinical Trials · 24

Works count: 55

Citation count: 3,877

H-index: 24

I10-index: 30